LEADER 00956nam0-22002891i-450- 001 990006094660403321 005 19980601 035 $a000609466 035 $aFED01000609466 035 $a(Aleph)000609466FED01 035 $a000609466 100 $a19980601g19041960km-y0itay50------ba 105 $a--------00-yy 200 1 $aCHRONICA minora. 210 $aLouvain$cSecretariat du CorpusSco$d1904-1960 215 $a6 v.$d25 cm 225 1 $aCorpus scriptorum Christianorum Orientalium$iScriptores Syri$v1 327 $a1.: Editit I. Guidi 2.: Interpretatus est I. Guidi 3.: Editit E.W. Brooks 4.: Interpretatus est I.B. Chabot 5.: Ediderunt Brooks, Guidi, Chabot$a6.: Interpretati sun Brooks, Guidi, Chabot 676 $a340.5 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006094660403321 952 $aIV Z OR 1 (1-6)$b14187*$fFGBC 959 $aFGBC 996 $aChronica minora$9239888 997 $aUNINA DB $aGIU01 LEADER 00782cac0 22001931 450 001 LAEC00024919 005 20110502121304.0 100 $a20110502f0000 |||||ita|0103 ba 102 $aBL 110 $ab 200 1 $aAegaeum 801 0$aIT$bUNISOB$c20110502$gRICA 912 $aLAEC00024919 940 $aC 121 Collana SBN 941 $aC 996 $aAegaeum$91015681 997 $aUNISOB 998 \\$1001E600200036444$12001 $aDefensible Sites in Crete (c.1200-800 B.C.)$e(LM IIIB-IIIC through Early Geometric) 998 \\$1001E600200047074$12001 $aThalassa$eL'Egée Prehistorique et la Mer$eActes de la troisième Rencontre égéenne internationale de l'Univerisité de Liège, Station de recherches sous - marine et océanographiques (StaReSO), Calvi, Corse (23 - 25 avril 1990) LEADER 02998nam 2200433z- 450 001 9910617309003321 005 20251017110132.0 035 $a(CKB)5850000000095840 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/92983 035 $a(oapen)doab92983 035 $a(DNLM)9918521665206676 035 $a(EXLCZ)995850000000095840 100 $a20202210d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aUrologic Cancers 210 $aBrisbane, Australia$cExon Publications$d2022 215 $a1 online resource 311 08$a0-645-33205-4 330 $aUrologic cancers are an umbrella term for cancers of the prostate, kidney, bladder, penis, and testis. Routine use of advanced imaging modalities for various reasons has increased the incidental detection of some of these cancers at an early stage. Robot-assisted surgery for nephrectomy, prostatectomy, cystectomy, and retroperitoneal lymph node dissection have improved surgical outcomes of localized disease. The introduction of targeted therapies since 2006 has revolutionized the management of metastatic kidney cancer. Despite these advances, the five-year survival of patients with advanced renal cancer is still poor and we need a better understanding of the disease. The book Urologic Cancers brings together an international team of clinicians and basic scientists to provide an up-to-date overview of a wide spectrum of topics that comprise epidemiological, pathological, clinical, and biological aspects of urologic cancers. From the epidemiological spectrum, the most recent information on the epidemiology of testicular cancer and penile cancer are presented. From the clinical spectrum, the characteristics and management of divergent urothelial neoplasms, the role of surgery in the management of testicular and kidney cancer, biopsy approaches for better detection and diagnosis of prostate cancer, the role of family history and germline genetics in prostate cancer disease profiling and screening, and the need for the implementation of quality assurance programs to improve prostate cancer care discussed. The biological aspects of disease mechanisms focus on various emerging molecular pathways and how these can be targeted to develop novel therapeutics. The contents of the book will be of interest to healthcare professionals, basic scientists and clinicians interested in urologic cancers. 606 $aMJCL$2bicssc 610 $abladder cancer 610 $akidney cancer 610 $apenile cancer 610 $aprostate cancer 610 $atesticular cancer 610 $aurologic cancers 615 7$aMJCL 700 $aBarber$b Neil$4edt$01319275 702 $aAli$b Ahmed$4edt 702 $aBarber$b Neil$4oth 702 $aAli$b Ahmed$4oth 906 $aBOOK 912 $a9910617309003321 996 $aUrologic Cancers$93033689 997 $aUNINA